Archive for July, 2008
Recent Rosacea Blog Posts
Clinuvel Pharmaceuticals has announced that they have been granted orphan-drug status by the FDA to treat the skin condition erythropoietic porphyrias. Orphan drug status is granted to new drugs that treat rare conditions and is used as an instrument to obtain accelerated review by the FDA. The FDA allows tax reductions and market exclusivity for […]
The news sites are buzzing with the announcement that the European Commision has granted marketing authority for Oracea. The first domestic approvals for Oracea will be granted in Germany, UK, Italy, Austria, Ireland, Sweden, Finland, Luxembourg, and the Netherlands. MediGene has the rights to sell Oracea throughout Europe. Local approvals are expected within 30 days. […]
This paper raises an interesting topic. The researchers were able to prove that 3 rosacea sufferers were allergic to alpha-tocopherol (Vitamin E) and Vitamin K. By eliminating the components of the creams they were using, they were able to isolate the individual components that were causing the allergy. Rosacea sufferers can become attuned to the […]
The American Acne & Rosacea Society have published a PDF containing their Rosacea Medical Management Guidelines. The aim of the guidelines is “to provide an overview of the fundamental disease state of rosacea and quality of life implications and outline available pharmacological treatments for rosacea with reference to supporting research and literature. The pharmacological agents […]
In the past there hasn’t been a lot of research into the relationship between rosacea and mental health. Many rosacea sufferers know that there is a strong relationship between their symptoms and how they feel about themselves. This abstract mentions some research comparing rosacea sufferers with people without any facial lesions. They found that the […]
